학술논문

NIVOLUMAB FOR RELAPSED OR REFRACTORY (R/R) CLASSICAL HODGKIN LYMPHOMA (CHL) AFTER AUTOLOGOUS TRANSPLANTATION: 5‐YEAR OVERALL SURVIVAL FROM THE PHASE 2 CHECKMATE 205 STUDY.
Document Type
Article
Source
Hematological Oncology; Jun2021 Supplement S2, Vol. 39, p1-4, 4p
Subject
Language
ISSN
02780232